EUVIMEDEUVIMED entdecken
Open Access · CC0

Concomitant western diet and chronic-binge alcohol dysregulate hepatic metabolism

Delfin Gerard Buyco, Joseph L Dempsey, Eleonora Scorletti, Sookyoung Jeon iD, Chelsea Lin iD, Julia Harkin, Susovon Bayen, Emma E Furth, Jasmin Martin iD, Monique Delima, Royce Hooks, Jaimarie Sostre-Colón und 3 weitere

PLOS ONE · 03.05.2023 · 18 (5) · e0281954

DOI: 10.1371/journal.pone.0281954 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 03.05.2023. Verfasst von Delfin Gerard Buyco und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United Sta…. Hauptthemen laut MEDLINE: Glucose Intolerance, Liver Diseases, Alcoholic, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIAAA NIH HHS, NIDDK NIH HHS, National Institute on Alcohol Abuse and Alcoholism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims There is significant overlap between non-alcoholic fatty liver disease (NAFLD) and alcohol-associated liver disease (ALD) with regards to risk factors and disease progression. However, the mechanism by which fatty liver disease arises from concomitant obesity and overconsumption of alcohol (syndrome of metabolic and alcohol-associated fatty liver disease; SMAFLD), is not fully understood.

Methods

Male C57BL6/J mice were fed chow diet (Chow) or high-fructose, high-fat, high-cholesterol diet (FFC) for 4 weeks, then administered either saline or ethanol (EtOH, 5% in drinking water) for another 12 weeks. The EtOH treatment also consisted of a weekly 2.5 g EtOH/kg body weight gavage. Markers for lipid regulation, oxidative stress, inflammation, and fibrosis were measured by RT-qPCR, RNA-seq, Western blot, and metabolomics.

Results

Combined FFC-EtOH induced more body weight gain, glucose intolerance, steatosis, and hepatomegaly compared to Chow, EtOH, or FFC. Glucose intolerance by FFC-EtOH was associated with decreased hepatic protein kinase B (AKT) protein expression and increased gluconeogenic gene expression. FFC-EtOH increased hepatic triglyceride and ceramide levels, plasma leptin levels, hepatic Perilipin 2 protein expression, and decreased lipolytic gene expression. FFC and FFC-EtOH also increased AMP-activated protein kinase (AMPK) activation. Finally, FFC-EtOH enriched the hepatic transcriptome for genes involved in immune response and lipid metabolism.

Conclusions

In our model of early SMAFLD, we observed that the combination of an obesogenic diet and alcohol caused more weight gain, promoted glucose intolerance, and contributed to steatosis by dysregulating leptin/AMPK signaling. Our model demonstrates that the combination of an obesogenic diet with a chronic-binge pattern alcohol intake is worse than either insult alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucose IntoleranceLiver Diseases, AlcoholicNon-alcoholic Fatty Liver DiseaseMiceAnimalsMaleLeptinDiet, WesternAMP-Activated Protein KinasesEthanolLiverObesityLipid MetabolismDiet, High-FatMice, Inbred C57BL

Substanzen

LeptinAMP-Activated Protein KinasesEthanol

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
  • Division of Gastroenterology, Department of Medicine, School of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Department of Food Science and Nutrition, Hallym University, Chuncheon, Gangwon-do, Republic of Korea.
  • Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
  • Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
  • Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, University of Washington, Seattle, Washington, United States of America.

ORCID-Profile: Sookyoung Jeon, Chelsea Lin, Jasmin Martin, Sina A Gharib

Förderung

  • NIAAA NIH HHS
  • NIDDK NIH HHS
  • National Institute on Alcohol Abuse and Alcoholism
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Buyco, D. G., Dempsey, J. L., Scorletti, E., Jeon, S., Lin, C., Harkin, J., Bayen, S., Furth, E. E., Martin, J., Delima, M., Hooks, R., Sostre-Colón, J., Gharib, S. A., Titchenell, P. M., & Carr, R. M. (2023). Concomitant western diet and chronic-binge alcohol dysregulate hepatic metabolism. PLOS ONE, 18(5), e0281954. https://doi.org/10.1371/journal.pone.0281954

Vancouver

Buyco DG, Dempsey JL, Scorletti E, Jeon S, Lin C, Harkin J, et al. Concomitant western diet and chronic-binge alcohol dysregulate hepatic metabolism. PLOS ONE. 2023;18(5):e0281954. doi:10.1371/journal.pone.0281954

BibTeX
@article{Buyco2023,
  author = {Buyco, Delfin Gerard and Dempsey, Joseph L and Scorletti, Eleonora and Jeon, Sookyoung and Lin, Chelsea and Harkin, Julia and Bayen, Susovon and Furth, Emma E and Martin, Jasmin and Delima, Monique and Hooks, Royce and Sostre-Colón, Jaimarie and Gharib, Sina A and Titchenell, Paul M and Carr, Rotonya M},
  title = {Concomitant western diet and chronic-binge alcohol dysregulate hepatic metabolism},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {5},
  pages = {e0281954},
  doi = {10.1371/journal.pone.0281954}
}
Kostenlos starten →